MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

Metrics as of 10/17/2026, 08:26 AM (Berlin time), refresh in progress.

STERIS Stock

STERIS plc

STENYSERadar
US$222.66
-0.7% today

Company data

Sector
Healthcare
Industry
Medical - Specialties
Country
United States
CEO
Daniel A. Carestio
Employees
17,937
Market cap
$21.7 B
IPO
01/06/1992

STERIS plc is a healthcare company headquartered in Mentor, US, and listed on the NYSE. The company provides infection prevention products and services across the United States, Ireland, and international markets. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences.…

Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.

STERIS stock: price history

16/10/25-7.3 %16/10/26

1D

-0.7%

1W

+3.9%

1M

+6.1%

6M

-1.4%

YTD

-12.2%

1Y

-7.3%

2Y

-1.5%

5Y

-1.1%

10Y

+220.1%

Next earnings date

Next earnings date

04/11/2026 (in 18 days)

Volatility around earnings

~53% stronger price swings than usual

Pattern chart

Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 13/10/26. Not a buy or sell signal.Beta

What does this mean?

Volatility squeeze

Bullish

Price swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.

Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.

Ask the agents about STERIS

Analyst assessment of STERIS

PRICE TARGET LOW

US$269.00

CONSENSUS

US$271.33

MEDIAN

US$270.00

PRICE TARGET HIGH

US$275.00

0

STRONG BUY

12

BUY

2

HOLD

0

SELL

0

STRONG SELL

14

TOTAL · Buy

As of: 07/08/2026

ANALYST FIRMRATINGACTIONDATE
UBSBuymaintain07/08/2026
Piper SandlerOverweightmaintain07/08/2026
KeybancOverweightmaintain13/05/2026
Morgan StanleyOverweightmaintain08/08/2025 (older than 12 months)
KeybancOverweightmaintain22/07/2025 (older than 12 months)
Morgan StanleyEqual Weight → Overweightupgrade15/07/2025 (older than 12 months)
Morgan StanleyEqual Weightmaintain19/05/2025 (older than 12 months)
JMP SecuritiesMarket Outperformmaintain16/05/2025 (older than 12 months)

STERIS stock metrics

P/E

27.15

P/B

3.02

EV/EBITDA

14.28

RETURN ON EQUITY

2.8%

NET MARGIN

13.4%

DEBT/EQUITY

0.28

DIVIDEND YIELD

1.2%

AS OF

30/06/2026

Free float & liquidity

FREE FLOAT

99.7%

FLOAT SHARES

97,167,722

AVG. DAILY VOLUME (30D)

670,719

Insider transactions (SEC)

ROLETRANSACTIONSHARESPRICEPLAN TYPEDATE

Burton Karen L

OfficerTax settlement228–Spontaneous05/10/2026

Sohi Mohsen

DirectorOption exercise4,05886.23Spontaneous12/08/2026

Sohi Mohsen

DirectorSale4,058235.78Spontaneous12/08/2026

Sohi Mohsen

DirectorOption exercise3,78171.4Spontaneous02/07/2026

Sohi Mohsen

DirectorTax settlement1,837212.3Spontaneous02/07/2026
Page 1 / 11

Attention

1 mention today in US forums, about the same as yesterdayPrice since yesterday: -0.7%

Forums (Reddit)

12/1013/1014/10

Institutional holders

FUND / INSTITUTIONSHARESCHANGEAS OF
FENIMORE ASSET MANAGEMENT INC354,742-47030/09/2026
Sustainable Growth Advisers, LP237,752-137,48530/09/2026
Copeland Capital Management, LLC177,778+21,35330/09/2026
CONGRESS ASSET MANAGEMENT CO /MA174,713+3,74630/09/2026
Assenagon Asset Management S.A.105,373+28,93330/09/2026
Page 1 / 3

Dividends & Stock splits

Dividends

EX-DATEPAY DATEAMOUNTYIELD
04/09/202625/09/2026US$0.691.1 %
08/06/202626/06/2026US$0.631.2 %
17/02/202619/03/2026US$0.631 %
18/11/202518/12/2025US$0.630.9 %
04/09/202526/09/2025US$0.631 %
Page 1 / 8

Stock splits

DATERATIO
25/08/19982:1
25/08/19952:1

Comparable stocks

Frequently asked questions about STERIS stock

What does STERIS do?

STERIS plc is a company in the Healthcare sector, Medical - Specialties industry, headquartered in United States.

The CEO is Daniel A. Carestio, the company employs around 17,937 people.

The IPO was on 01/06/1992; the stock trades on NYSE under the ticker STE.

What do analysts say about STERIS stock?

14 analysts rate the stock, the consensus is Buy (as of 07/08/2026).

The average price target is US$271.33, ranging from US$269.00 to US$275.00, with a median of US$270.00.

This is an external assessment, not a statement by Market Jury.

When does STERIS report next?

The next earnings date is 04/11/2026.

Around past earnings, price swings were roughly 53% stronger than usual.

Does STERIS pay a dividend?

Yes. The last dividend was US$0.69 per share, ex-date 04/09/2026, paid on 25/09/2026.

The dividend yield is 1.2% (as of 30/06/2026).

Which stocks are comparable to STERIS?

Comparable stocks include QuidelOrtho, Mesa Laboratories, 908 Devices, Trinity Biotech, Eli Lilly and Company, Johnson & Johnson, AbbVie and Merck &.

How can I get STERIS stock analyzed?

Clicking "Analyze stock" lets five strategies assess STERIS against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.